The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1972, 108: 505-512.
Copyright © 1972 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braude, A. I.
Right arrow Articles by Douglas, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Braude, A. I.
Right arrow Articles by Douglas, H.

Passive Immunization against the Local Shwartzman Reaction1

Abraham I. Braude and Herndon Douglas

Department of Medicine and Pathology, University of California-San Diego, School of Medicine, San Diego, California

Abstract

Passive immunization with rabbit antiserum to endotoxin prevented the Shwartzman reaction due to homologous and heterologous endotoxins. Homologous protection lasted at least 1 month, was conferred with the 19S fraction, and was accompanied by accelerated clearance of radioactive endotoxin from the circulating blood. Heterologous protection was not accompanied by accelerated clearance of endotoxin and bore no relationship to "0" antibody. Antiserum to the epimerase-deficient rough mutant J5 of Escherichia coli 0:111, which cannot incorporate "0" antigenic units, gave better protection than antiserum to smooth endotoxins. These results indicate that antiserum prevents the Shwartzman reaction by action against a toxic antigen common to endotoxins from unrelated bacterial genera; that loss of "0" antigenic units may enhance the production of protective antisera; and that accelerated clearance of endotoxin from the circulation is not necessary for protection.

Footnotes

1 This work was supported by United States Army Contract Med/DADA 17-69-C-9161 and United States Public Health Service Grant AI-10108-01.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Muller-Loennies, L. Brade, C. R. MacKenzie, F. E. Di Padova, and H. Brade
Identification of a Cross-reactive Epitope Widely Present in Lipopolysaccharide from Enterobacteria and Recognized by the Cross-protective Monoclonal Antibody WN1 222-5
J. Biol. Chem., July 3, 2003; 278(28): 25618 - 25627.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
P.H. Lagrange, H.S. Blanchard, and A. Felten
Review: Bacterial endotoxin and the human monoclonal antibody HA-IA: specificity, potential mechanisms of action, and limits to its effectiveness
Innate Immunity, October 1, 1995; 2(5): 371 - 386.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
A.S. Cross and S. Opal
Minireview: Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?
Innate Immunity, March 1, 1994; 1(1): 57 - 69.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1972 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1972 by The American Association of Immunologists, Inc. All rights reserved.